For patients with moderate to severe asthma, blockade with itepekimab, a new human IgG4P monoclonal antibody against the upstream alarmin interleukin-33, led to a reduction in events that indicate ...
A revised HEDIS definition of high-risk asthma more precisely identifies patients with functional impairment and higher healthcare utilization who might benefit from case management. : To develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results